Medicare has just added another 15 drugs to the Medicare Maximum Fair Prices (MFPs) for prices that will take effect on January 1, 2027. The negotiations for these price cuts began under President Joe Biden, who is still looking out for us all in ways that the temporary R majorities and the broligarchy have not dared to take on. This program is set to continue at 15 drugs per year until we have deals on all of the drugs that Medicare was previously not allowed to negotiate over.
I make no promises about what the [redacted, but you know what I mean] will try in January, when the next group of 15 is due to be selected. Neither does he/it. He doesn’t yet know what he wants to do then.
Finding this list was not easy for me, but it’s easier for you:
According to the CMS, the 15 drugs included in this second round and their negotiated 30-day supply prices, compared to 2024 list prices, are:
- Ozempic, Rybelsus, Wegovy (Type 2 diabetes/weight loss): $274 (was $959; Wegovy higher dose: $385)
- Trelegy Ellipta (asthma): $175 (was $654)
- Xtandi (prostate cancer): $7,004 (was $13,480)
- Pomalyst (chemotherapy): $8,650 (was $21,744)
- Ofev (idiopathic pulmonary fibrosis): $6,350 (was $12,622)
- Ibrance (breast cancer): $7,871 (was $15,741)
- Linzess (chronic constipation): $136 (was $539)
- Calquence (cancer): $8,600 (was $14,228)
- Austedo & Austedo XR (Huntington’s disease): $4,093 (was $6,623)
- Breo Ellipta (COPD): $67 (was $397)
- Xifaxan (IBS/diarrhea): $1,000 (was $2,696)
- Vraylar (antipsychotic): $770 (was $1,376)
- Tradjenta (diabetes): $78 (was $488)
- Janumet & Janumet XR (diabetes): $80 (was $526)
- Otezla (psoriatic arthritis): $1,650 (was $4,722)
Thanks, Joe! 💙
Three diabetes drugs highlighted.
Medicare Announces Price Cuts for 15 Prescription Drugs Thanks to BIDEN democrats.org/...
Thanks to Democrats’ Inflation Reduction Act, Medicare announced price cuts for 15 prescription drugs — a key tenet of President Joe Biden’s agenda.
Let’s be clear: These particular drugs were selected for negotiation in January, while Biden was still in office
“Donald Trump’s failed record on health care and lowering costs is so egregious that the only accomplishments he can claim under his term are thanks to President Biden.
It’s a brutal split screen: While President Biden’s legacy continues to deliver for working families, Trump wants to raise your health care costs.”
Smilin Joe still gettin it done 😎😎
Now we have to wait to hear what the insurance companies are going to do about it. Which of these drugs are in their formularies? What further deals can they offer?
Full List of Prescription Drug Prices Being Cut by Medicare
These cuts, amounting to a net savings of $12 billion from last year's Medicare spending, come as the cost of prescription medications remains a significant concern for millions of Americans, especially seniors.
On November 25, the CMS announced that new negotiated Maximum Fair Prices (MFPs) for 15 drugs will take effect on January 1, 2027.
These price cuts follow ongoing policy efforts shaped by the Inflation Reduction Act, a policy initiative led by former President Joe Biden
Tradjenta
If your A1C is still too high, maybe it’s a sign
For adults with type 2 diabetes along with diet and exercise
Along with diet and exercise, TRADJENTA helps your body lower blood sugar in two ways
- Helps the pancreas produce more insulin
- Helps the liver produce less sugar
Janumet
Janumet contains a combination of metformin and sitagliptin. Metformin and sitagliptin are oral diabetes medicines that help control blood sugar levels.
Metformin works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines. Sitagliptin works by regulating the levels of insulin your body produces after eating.
Janumet is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
